Latest / FYI - For Your Innovation

Moderna's Cancer Vaccine May Cut Deaths In Half | The Brainstorm 146
In this episode of The Brainstorm, Sam, Nick, and Brett break down Merck and Moderna’s positive Phase 3 results for a personalized mRNA cancer vaccine, a treatment custom-built from each patient’s own tumor that cut mortality from advanced melanoma by roughly 50% versus the standard of care. The team digs into cost, manufacturing scale, and why the capital poured into mRNA during COVID may be paying off in oncology. Then Brett reports back from a weekend with Grok Bot, which recovered $75 of his wife’s forgotten escrow money on its first task, and the team debates why multiplayer agents could…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.